878197-91-2

Usage

Uses

Used in Pharmaceutical Industry:
2-(DICHLOROMETHYL)-5-FLUOROIMIDAZO[1,2-A]PYRIDINE is used as a building block for the synthesis of new drugs for the treatment of various diseases. Its unique structure and properties make it a promising candidate for medicinal chemistry research and drug development.
Used in Medicinal Chemistry Research:
2-(DICHLOROMETHYL)-5-FLUOROIMIDAZO[1,2-A]PYRIDINE is used as a research compound to study its potential applications in medicinal chemistry. Further research is needed to fully understand its characteristics, properties, and potential uses in the development of new drugs.
Note: The specific applications and reasons for using 2-(DICHLOROMETHYL)-5-FLUOROIMIDAZO[1,2-A]PYRIDINE in different industries are not provided in the given materials. The information above is based on the general description and potential uses mentioned in the materials.

Upstream product

• 918-00-3 1,1,1-trichloroacetone 
• 1597-32-6 6-fluoro-pyridin-2-ylamine 
• 921-03-9 1,1,3-trichloroacetone 

Downstream Products

• 878197-67-2 5-fluoroimidazo[1,2-a]pyridine-2-carbaldehyde 

Relevant academic research and scientific papers

Imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV-1

Synthesis of several novel imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV are described. Synthetic approaches allowing for variation of the substitution pattern are outlined and resulting changes in antivir

CHEMICAL COMPOUNDS

The present invention provides compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a

CHEMICAL COMPOUNDS

The present invention provides compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a

CHEMICAL COMPOUNDS

The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a recep

CHEMICAL COMPOUNDS

There is provided novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as C

CHEMCIAL COMPOUNDS

The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 and/or CCR5 of a target cell.